First Time Loading...

Brii Biosciences Ltd
HKEX:2137

Watchlist Manager
Brii Biosciences Ltd Logo
Brii Biosciences Ltd
HKEX:2137
Watchlist
Price: 1.34 HKD 5.51% Market Closed
Updated: May 19, 2024

Brii Biosciences Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Brii Biosciences Ltd
Cash from Operating Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Brii Biosciences Ltd
HKEX:2137
Cash from Operating Activities
-¥594m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-¥7.8B
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Operating Activities
¥147.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
¥1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
¥5.8B
CAGR 3-Years
14%
CAGR 5-Years
134%
CAGR 10-Years
43%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Operating Activities
¥1.2B
CAGR 3-Years
57%
CAGR 5-Years
70%
CAGR 10-Years
N/A

See Also

What is Brii Biosciences Ltd's Cash from Operating Activities?
Cash from Operating Activities
-594m CNY

Based on the financial report for Dec 31, 2023, Brii Biosciences Ltd's Cash from Operating Activities amounts to -594m CNY.

What is Brii Biosciences Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-14%

Over the last year, the Cash from Operating Activities growth was -20%. The average annual Cash from Operating Activities growth rates for Brii Biosciences Ltd have been -14% over the past three years .